Search

Myron Frederick Weiner, M.D., Professor Emeritus of Psychiatry at UT Southwestern Medical Center and a noted clinical researcher in geriatric psychiatry and Alzheimer’s disease, died July 17 in Dallas. He was 89.

Carlos L. Arteaga, M.D., Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center, and David Mangelsdorf, Ph.D., Chair and Professor of Pharmacology and Professor of Biochemistry, have been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.

Children who had preexisting health problems or who lived in the Southern United States had a higher risk for severe health outcomes from acute COVID-19 infections, according to researchers at UT Southwestern Medical Center.

UT Southwestern Medical Center biologists have innovated a new stem cell-based embryo model for studying early human development, tissue formation, and differentiation, offering valuable contributions to the field of developmental biology and regenerative medicine.

Whether you’re hosting summer backyard cookouts or escaping the heat with indoor gatherings, a nutrition expert at UT Southwestern Medical Center says there are lots of options for adding some nutrition to your plate.

A newly discovered “timekeeper” for fighting infections dramatically shapes the body’s immune defenses.

Adults who developed severe obesity before the age of 18 were nearly three times more likely than those who developed the condition later to be subjected to severe experienced weight stigma (EWS), a study led by UT Southwestern Medical Center researchers shows.

Studies look at measuring blood flow velocity, a treatment strategy for non-small cell lung cancer, and the body’s response to airborne pathogens.

Zhijian “James” Chen, Ph.D., Professor in the Department of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on innate immunity, has been awarded the 2026 Elaine Redding Brinster Prize in Science or Medicine.

Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows.